已收盤 09-05 16:00:00 美东时间
-0.010
-0.45%
NexGel (NASDAQ:NXGL) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.07) by 28.57 percent. This is a 35.71 percent increase over losses of $(0.14) per share from the same
08-13 05:58
Companies Reporting Before The Bell • Smithfield Foods (NASDAQ:SFD) is expected...
08-12 16:32
NexGel (NASDAQ:NXGL) is gearing up to announce its quarterly earnings on Tuesda...
08-12 03:04
NEXGEL, Inc. (NASDAQ: NXGL), a leading provider of ultra-gentle hydrogel products, announced it will report its second quarter 2025 financial results after the market close on August 12, 2025. A conference call will be held at 4:30 P.M. ET on the same day, with a replay available through August 26. The call can be accessed via 1-800-274-8461 (U.S.) or 1-203-518-9814 (Int'l), with a webcast available at the provided link. An archived webcast will ...
08-06 12:00
NexGel Inc ( ($NXGL) ) has shared an announcement. On July 31, 2025, NEXGEL, In...
08-06 04:51
NEXGEL, Inc. announced the appointment of Steve Ciardiello, CPA, to its Board of Directors. With over 25 years of experience as a senior finance executive and current Chief Accounting Officer of Shutterstock, Inc., Mr. Ciardiello brings significant financial leadership and expertise to NEXGEL as it enters a new growth phase. His experience includes financial transformation initiatives, improved reporting efficiency, and streamlining financial ope...
08-05 12:00
NEXGEL shares are trading higher after the company announced a $950K registered...
08-02 01:57
NEXGEL, Inc. (NASDAQ: NXGL) announced the issuance and sale of 413,044 shares of common stock at $2.30 per share, along with warrants to purchase up to 206,522 shares with an exercise price of $4.25 per share and a 5-year term. The financing, combined with existing cash and a $1 million non-dilutive advance, strengthens the company's balance sheet and supports anticipated growth. Alere Financial Partners acted as the placement agent. The shares a...
08-01 12:00
NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced expanding its partnership with
07-14 21:04
NEXGEL, Inc. expands partnership with STADA Arzneimittel AG to launch digestive enzyme formulas and scar/stretch mark solutions in North America. STADA provides $1 million in non-dilutive capital for product launches and marketing. NEXGEL CEO Adam Levy expressed gratitude for STADA’s support and its acceleration of their joint go-to-market strategy.
07-14 13:00